CNE100000GF1
CNE100000GF1
CHASE SUN PHARM.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 9.97B EUR | 8.71B EUR | 10.63B EUR |
Enterprise Value | 8.81B EUR | 7.42B EUR | 9.59B EUR |
Valuation Multiples | |||
Trailing P/E | 332x | 90.38x | 73.68x |
Forward P/E | 8.1x | -- | -- |
Price to Sales | 2.3x | 2.43x | 2.71x |
Price to Book | 1.17x | 1.02x | 1.24x |
EV/Revenue | 2.03x | 2.07x | 2.44x |
EV/EBITDA | 19.76x | 35.62x | 36.45x |
Price to FCF (P/FCF) | 12.71x | 15.57x | 28.62x |
EV/FCF | 11.23x | 13.26x | 25.82x |
FCF Yield | 7.86% | 6.42% | 3.49% |